Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by M Akdis and Jean Bousquet.
M Akdis
Connection Strength
1.885
Jean Bousquet
  1. ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020). Allergy. 2021 03; 76(3):689-697.
    View in: PubMed
    Score: 0.226
  2. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19. Allergy. 2021 03; 76(3):735-750.
    View in: PubMed
    Score: 0.226
  3. Is diet partly responsible for differences in COVID-19 death rates between and within countries? Clin Transl Allergy. 2020; 10:16.
    View in: PubMed
    Score: 0.221
  4. Comparison of regulatory B cells in asthma and allergic rhinitis. Allergy. 2019 04; 74(4):815-818.
    View in: PubMed
    Score: 0.200
  5. Highlights and recent developments in airway diseases in EAACI journals (2017). Clin Transl Allergy. 2018; 8:49.
    View in: PubMed
    Score: 0.199
  6. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy. 2017; 7:5.
    View in: PubMed
    Score: 0.176
  7. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016; 6:47.
    View in: PubMed
    Score: 0.175
  8. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper. Allergy. 2021 03; 76(3):648-676.
    View in: PubMed
    Score: 0.058
  9. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 11; 75(11):2764-2774.
    View in: PubMed
    Score: 0.057
  10. [Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]. Laryngorhinootologie. 2020 10; 99(10):676-679.
    View in: PubMed
    Score: 0.056
  11. A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy. 2020 10; 75(10):2503-2541.
    View in: PubMed
    Score: 0.056
  12. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020 07; 75(7):1546-1554.
    View in: PubMed
    Score: 0.056
  13. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis. Rhinology. 2017 Sep 01; 55(3):202-210.
    View in: PubMed
    Score: 0.046
  14. Computational analysis of multimorbidity between asthma, eczema and rhinitis. PLoS One. 2017; 12(6):e0179125.
    View in: PubMed
    Score: 0.045
  15. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017 Sep; 72(9):1297-1305.
    View in: PubMed
    Score: 0.045
  16. Mechanisms of the Development of Allergy (MeDALL): Introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol. 2017 02; 139(2):388-399.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.